The penny stocks focused on the marijuana industry are starting to heat up again and one particular one is looking sexier than the others. On Tuesday, Meadpoint Venture Partners, Inc., the exclusive licensee of the FusionPharm, Inc. (PINK: FSPM) patent pending PharmPods High Intensity container hydroponic cultivation system, struck a deal with a cannabis boutique in Denver, Colorado. The deal in which GroundSwell will incorporate the Company’s PharmPod system with the additional 11 unit purchase suddenly makes FSPM stock worth watching, especially since they have a “roach” of a share structure to them.
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
FSPM Stock Quote
Market Cap: 2.16M
Tuesday Close: 0.3801 ▲ +0.0001 (+0.03%)
Dollar Volume: $25,150
Issued and Outstanding: 5,675,650
14-Day Rel Strength: 60.94%
1st Resistance Point: 0.4267
1st Support Level: 0.3567
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
FusionPharm is a very interesting company in a very hot market, the cannabis market. Although their are doubts to the timeline as to when marijuana will be as easy to purchase as a bottle of Johnny Walker Blue.
The Company makes and sells hydroponic cultivation systems (a system which grows any kind of plants without soil) they call PharmPods. The systems are made out of standard ISO steel shipping containers that are creatively recycled and equipped with high quality hydroponic lighting, irrigation systems, climate control and the ventilation set ups required to get the best grow-ready, self-contained portable agricultural solution available.
For those that have ever grown or tried to grow marijuana on their own, they can attest that a weed will grow with almost any combination of earth, light, water and air. To get that sticky dank that allows for high quality seeds to produce the highest levels of tetrahydrocannabinol, aka THC, precise control of what a plant receives is a much better method to grow dense crops with increased yields while avoiding the use of nasty pesticides and herbicides, as well as having to manually water on a scheduled basis, hydroponic systems are the only way to get anything worth selling.
Back in November of last year, FusionPharm entered into a licensing and distribution agreement with Meadpoint Venture Partners LLC. The deal called for Meadpoint to be the primary distributor of the Company’s PharmPod. After an initial order for 8 PharmPod containers, minimum purchase quantities of 50 containers in both 2013 and 2014 were inked into the deal.
With the 11 additional containers GroundSwell Cannabis Boutique has agreed to purchase, sales for Q3 should be more than adequate to push FSPM stock upwards.
As for the moment, the only financial data to trade off of was the $171,600 in revenues FusionPharm booked during Q1 which ended March 31, 2013. For the period, the Company reported net income of $9,453 which equated to EPS of $0.01 per share.
Earlier this month, shares of FSPM flooded the market when, on August 9th, 628,402 shares traded, more than 6X the highest volume session of the previous 12 months. In fact, over the past 12 months, shares of FSPM were actively traded during which time the share price declined from $1.99 to as low as 0.08 on July 26th.
There is no telling whether or not the share structure for FusionPharm will be as sexy as it was when the Company reported their most recent filings with OTCMarkets for the period ended March 31, 2013. That said, if it stays as tight as it is when they update their filings, a surge of attention on this low float marijuana sector play could send FSPM back to the $1 level with ease.
About FSPM Stock
FusionPharm, Inc. is a development stage company focused on the medical marijuana industry by manufacturing a commercial hydroponic cultivation system called PharmPods.
Last 5 Trading Sessions:
If you have nothing against investing into marijuana focused penny stocks, it would behoove you add FSPM to your watchlist. For a number of reasons like share structure, float, revenues, growth opportunities and just simply sexiness, FSPM stock could triple or better from its current level with the proper reporting and periodical updates from the Company like yesterday.
Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter
If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)Share